Study details
Enrolling now
Aviclear Trial for Hidradenitis Suppurativa
University of Miami
NCT IDNCT06801795ClinicalTrials.gov data as of Apr 2026
Target enrollment
8
Study length
about 1 year
Ages
18–60
Locations
1 site in FL
What this study is about
Researchers are testing a device called Aviclear to treat hidradenitis suppurativa (HS). The trial will last about 382 days and involve approximately 8 participants. The goal is to evaluate the safety and effectiveness of this treatment.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use AviClear
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: Change in pain as measured by Visual Analogue Scale Pain Rating Scale